Epidiolex maker GW Pharmaceuticals to be sold to Jazz Pharmaceuticals

Posted by - February 4, 2021

The major cannabis company has seen its stock rise following the announcement of the sale From its very inception, GW Pharmaceuticals has concentrated its research and development on medical problems and how to cure, or at least treat, them with cannabis-based products. Early on, they came up with a formula that treats children with severe

FDA approves Epidiolex to treat additional types of seizures

Posted by - August 5, 2020

The cannabis drug had already been greenlighted to treat epilepsy and now gets additional support Pharmaceutical companies are turning their eyes to the potential that cannabis has to treat different ailments. A British company involved in the development and manufacturing of plant-derived cannabinoid therapy, GW Pharmaceuticals, through its subsidiary Greenwich Biosciences, Inc. developed a cannabis-based

DEA removes CBD-based medicine from list of federal controlled substances

Posted by - April 7, 2020

Epidiolex is officially free from federal cannabis-limiting barriers The current hemp regulation, along with the increased market acceptance of cannabidiol (CBD) products, has made the Drug Enforcement Administration (DEA) approve the removal of a CBD-based prescription drug from the list of federally controlled substances. It was announced yesterday by GW Pharmaceuticals, that its propietary prescription

CBD could help other forms of seizures

Posted by - December 9, 2019

Epileptic seizures may not be the only kind to benefit from CBD consumption A new preliminary study suggests that cannabidiol (CBD), more specifically, the prescription-grade kind, is a good option to control seizures caused by a rare genetic disorder that is hard to treat. Tuberous sclerosis complex (TSC) is a health condition caused by the

Medical marijuana now approved by the TSA

Posted by - May 28, 2019

The Transportation Security Administration updated its policies this past weekend Take a look at the “What Can I Bring?” section of the Transportation Security Administration’s (TSA) website and you may notice a change. Medical marijuana is no longer a prohibited substance – with certain caveats. The update was made with little fanfare over this past

Cannabis-based Epidiolex for epilepsy now available for purchase

Posted by - November 2, 2018

FDA-approved Epidiolex can now be prescribed in the U.S. Following approval by the Food & Drug Administration (FDA) this past June, the first cannabis-based drug for treating epilepsy is now officially available. The drug, which was created by GW Pharmaceuticals, went on sale as of yesterday and is approved for patients two years old or